Kurmanova Almagul, Ashirbekov Yeldar, Kurmanova Gaukhar, Mamedaliyeva Nagima, Anartayeva Gaini, Moshkalova Gaukhar, Salimbayeva Damilya, Tulesheva Aidana, Zhankina Zhamilya
Faculty of Medicine and Healthcare, Al Farabi Kazakh National University, 71, Al-Farabi Avenue, 050040 Almaty, Kazakhstan.
Laboratory of Structural and Functional Genomics, M. Aitkhozhin Institute of Molecular Biology and Biochemistry, 86, Dosmukhamedov Street, 050012 Almaty, Kazakhstan.
J Clin Med. 2024 Oct 17;13(20):6184. doi: 10.3390/jcm13206184.
Reproductive disorders are common events in modern reproductive medicine, occurring both in spontaneous and assisted pregnancies. Studies on the molecular mechanisms of implantation disorders in thin endometria, including the study of gene transcriptional activities, have shed light on the identification of the potential biological markers of endometrial receptivity. : The goal of this study was to reveal the significantly dysregulated selected gene expressions between RIF and RPL patients with thin endometria. : Endometrial samples were collected from RIF patients ( = 20) and RPL patients ( = 19) during the implantation window days (LH + 7-LH + 10) of their natural menstrual cycles. Ten genes were chosen as the target genes regarding their possible relations with the implantation process. The total RNA was purified and reverse-transcribed, and gene expressions were quantified by RT-PCR. : The expressions of the , , and genes were significantly decreased in the RIF patients with thin endometria compared to the RPL patients (log fold change = 0.92, = 0.023 for ; log fold change = 1.24, = 0.046 for ; and log fold change = 0.579, = 0.046 for ). There were no significant differences in the expressions of the , , , , , , and genes between the groups. : Decreased expressions of the , and genes were found in patients with RIF with thin endometria compared to the endometria of women with RPL. This has practical significance for clinicians for the differentiated prescription of immunomodulatory therapy in patients undergoing ART programs.
生殖障碍是现代生殖医学中的常见情况,在自然妊娠和辅助妊娠中均会发生。对薄型子宫内膜着床障碍分子机制的研究,包括基因转录活性的研究,为子宫内膜容受性潜在生物标志物的鉴定提供了线索。本研究的目的是揭示薄型子宫内膜的反复种植失败(RIF)患者和复发性流产(RPL)患者之间选定基因表达的显著失调情况。在自然月经周期的着床窗期(LH + 7 - LH + 10),从RIF患者(n = 20)和RPL患者(n = 19)中采集子宫内膜样本。根据与着床过程的可能关系选择了10个基因作为靶基因。纯化总RNA并进行逆转录,通过RT-PCR定量基因表达。与RPL患者相比,薄型子宫内膜的RIF患者中,[具体基因1]、[具体基因2]和[具体基因3]基因的表达显著降低([具体基因1]:log倍变化 = 0.92,P = 0.023;[具体基因2]:log倍变化 = 1.24,P = 0.046;[具体基因3]:log倍变化 = 0.579,P = 0.046)。两组之间[其他基因名称]基因的表达没有显著差异。与RPL女性的子宫内膜相比,薄型子宫内膜的RIF患者中[具体基因1]、[具体基因2]和[具体基因3]基因的表达降低。这对临床医生在接受辅助生殖技术(ART)程序的患者中进行免疫调节治疗的差异化处方具有实际意义。